Stryker Corporation (SYK) Monthly Report
Publication Date: September 22, 2024
Company Overview
Stryker Corporation (SYK), founded in 1941 and headquartered in Portage, Michigan, is a leader in the medical devices industry, operating primarily within the healthcare sector. The company is structured into two major divisions: Orthopaedics and Spine, which includes implants for joint replacements and trauma surgeries, and MedSurg and Neurotechnology, which offers surgical equipment across various specialties, including neurosurgery. Stryker’s innovative products are distributed globally, reaching healthcare professionals in around 75 countries. With a total revenue of approximately $21.39 billion, Stryker demonstrates strong financial health and positions itself well for future growth in a competitive market.
Investment Outlook
Currently trading at $364.81, Stryker’s stock has a target high price projected at $410.00, indicating significant potential for upside as the company continues to navigate the evolving healthcare landscape. The target mean price is estimated at $377.65, reinforcing analysts’ positive outlook. A total of 381,075,008 shares are outstanding, with 4,447,858 shares shorted, equating to a short percentage of float of approximately 1.23%. This modest short interest suggests a stable investment environment despite some bearish sentiments. Analysts’ recommendations reveal a consensus “buy” signal, supported by an average recommendation score of 2.0 from 27 analysts, indicating confidence in Stryker’s potential to capture market growth.
Market Performance
The stock is currently positioned below its fifty-two week high of $374.63 but notably above its fifty-two week low of $249.98, signaling a healthy recovery trajectory over the past year. The fifty-day moving average stands at $344.71, suggesting that the current price is gaining bullish momentum. While further insights into Stryker’s EBITDA could enhance understanding of its profitability, the overall data indicates a promising outlook for the stock. Investors are encouraged to keep an eye on Stryker Corporation as it continues to leverage its strong market presence and operational success for future profitability.
| Metric | Value |
|---|---|
| Market Cap | $139.0b |
| Total Debt | $12.7b |
| Total Cash | $2.0b |
| Shares Outstanding | 381.1m |
| Float Shares | 341.9m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.